Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 30, 2016 - Issue 4
410
Views
19
CrossRef citations to date
0
Altmetric
Short Communication

Antiproliferative effect of isolated isoquinoline alkaloid from Mucuna pruriens seeds in hepatic carcinoma cells

, , , , , , & show all
Pages 460-463 | Received 09 Jan 2015, Accepted 10 Feb 2015, Published online: 16 Mar 2015
 

Abstract

The present study was undertaken to investigate the antiproliferative action of isolated M1 (6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid) from Mucuna pruriens seeds using human hepatic carcinoma cell line (Huh-7 cells). Initially, docking studies was performed to find out the binding affinities of M1 to caspase-3 and 8 enzymes. Later, cytotoxic action of M1 was measured by cell growth inhibition (MTT), followed by caspase-3 and 8 enzymes assay colorimetrically. Our results collectively suggested that M1 had strong binding affinity to caspase-8 in molecular modelling. M1 possessed antiproliferative activity on Huh-7 cells (EC50 = 13.97 μM) and also inhibited the action of caspase-8 enzyme, signified process of apoptosis. M1 was active against Huh-7 cells that may be useful for future hepatic cancer treatment.

Acknowledgement

We are thankful to Director, CBMR, Lucknow for providing NMR facilities.

Additional information

Funding

Dr Sudipta Saha (corresponding author) would like to thank the University Grants Commission (UGC), New Delhi, India, for providing UGC Start-Up-Grant [grant number F. 20-1/2012 (BSR)/20-7 (15)/2012 (BSR)].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.